Search

263 results for “treatment”

• Research PaperOpen Access

  Identification of risk factors for carbamazepine‑induced serious mucocutaneous adverse reactions: A case‑control study using data from spontaneous adverse drug reaction reports

  Ilma Bertulyte, Sofie Schwan, Pär Hallberg

  Vol. 5 · Issue 2 · pp. 100–138

  https://doi.org/10.4103/0976-500X.130051
  Full text ↗PDF

• Review ArticleOpen Access

  Metronomic chemotherapy

  Rituparna Maiti

  Vol. 5 · Issue 3 · pp. 186–192

  https://doi.org/10.4103/0976-500X.136098
  Full text ↗PDF

• CommentaryOpen Access

  The new factor Xa inhibitor: Apixaban

  Sangeeta Bhanwra, Kaza Ahluwalia

  Vol. 5 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.124409
  Full text ↗PDF

• Research PaperOpen Access

  Folic acid supplementation on homocysteine levels in children taking antiepileptic drugs: A randomized controlled trial

  Mathummal Cherumanalil Jeeja, Thayyil Jayakrishnan, Puthiya Veettil Narayanan, Mathur Sreedharan Vinod Kumar, Thayyil Thejus, Vadakay Purayil Anilakumari

  Vol. 5 · Issue 2 · pp. 93–94

  https://doi.org/10.4103/0976-500X.130048
  Full text ↗PDF

• Case ReportOpen Access

  Anticonvulsant hypersensitivity syndrome associated with carbamazepine administration: Case series

  Maulin Mehta, Jay Shah, Tejas Khakhkhar, Rima Shah, K. G. Hemavathi

  Vol. 5 · Issue 1 · pp. 59–60

  https://doi.org/10.4103/0976-500X.124428
  Full text ↗PDF

• Research PaperOpen Access

  Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India

  Binit N. Jhaveri, Tejas K. Patel, Manish J. Barvaliya, C. B. Tripathi

  Vol. 5 · Issue 1 · pp. 15–16

  https://doi.org/10.4103/0976-500X.124411
  Full text ↗PDF

• CommentaryOpen Access

  Dextropropoxyphene ban in India: Is there a case for reconsideration?

  Yatan Pal Singh Balhara

  Vol. 5 · Issue 1 · pp. 8–9

  https://doi.org/10.4103/0976-500X.124406
  Full text ↗PDF

• Case ReportOpen Access

  Recurrence of atrial fibrillation after switching from brand to generic atenolol

  Luca Gallelli, Francesca Maida, Orietta Staltari, Pierandrea Rende, Emilio Russo, Benedetto Caroleo

  Vol. 5 · Issue 1 · pp. 158–160

  https://doi.org/10.4103/0976-500X.149146
  Full text ↗PDF

• Research PaperOpen Access

  Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in‑patients of a tertiary care hospital of India

  Turhan Dost, Samet Kafkas, Filiz Gokalp, Aslihan Karul, Mustafa Birincioglu

  Vol. 5 · Issue 1 · pp. 21–22

  https://doi.org/10.4103/0976-500X.124413
  Full text ↗PDF

• Educational ForumOpen Access

  Off‑label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities

  Sandeep Kumar Gupta, Roopa Prasad Nayak

  Vol. 5 · Issue 2 · pp. 88–92

  https://doi.org/10.4103/0976-500X.130046
  Full text ↗PDF

• Research LetterOpen Access

  Cannabis use among opioid-dependent individuals on opioid substitution therapy

  Yatan Pal Singh Balhara, Raka Jain

  Vol. 5 · Issue 3 · pp. 203–205

  https://doi.org/10.4103/0976-500X.136106
  Full text ↗PDF

• Case ReportOpen Access

  Ganciclovir–tenofovir interaction leading to tenofovir‑induced nephrotoxicity

  Radhika Soanker, Shobha Jagdish Chandra Udutha, Malladi V S Subbalaxmi, YSN Raju

  Vol. 5 · Issue 4 · pp. 265–267

  https://doi.org/10.4103/0976-500X.142452
  Full text ↗PDF

• Case ReportOpen Access

  Periodic paralysis: An unusual presentation of drug‑induced hyperkalemia

  Poonam Agrawal, Deepti Chopra, Surajeet K. Patra, Himanshu Madaan

  Vol. 5 · Issue 1 · pp. 63–64

  https://doi.org/10.4103/0976-500X.124429
  Full text ↗PDF

• Case ReportOpen Access

  Angioedema due to fixed dose combination of telmisartan plus ramipril

  Vishal R. Tandon, Annil Mahajan, Vijay Khajuria, Zahid H. Gillani

  Vol. 5 · Issue 3 · pp. 214–216

  https://doi.org/10.4103/0976-500X.136113
  Full text ↗PDF

• Case ReportOpen Access

  Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure

  Sachin R. Agrawal, Atul Rajput, A. P. Jain

  Vol. 5 · Issue 4 · pp. 268–270

  https://doi.org/10.4103/0976-500X.142453
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Delamanid: A new armor in combating drug‑resistant tuberculosis

  Alphienes Stanley Xavier, Mageshwaran Lakshmanan

  Vol. 5 · Issue 3 · pp. 222–224

  https://doi.org/10.4103/0976-500X.136121
  Full text ↗PDF

• Letter to the EditorOpen Access

  Reply to “Good! is it the best ???

  Aditi Chaturvedi, Yogendra Singh, Harish Chaturvedi, Vijay Thawani, Sakshi, Deepak Parihar

  Vol. 4 · Issue 3 · pp. 221–222

  https://doi.org/10.4103/0976-500X.114622
  Full text ↗PDF

• EditorialOpen Access

  Bridging the gap between alternative medicine and evidence-based medicine

  Mostafa Yakoot

  Vol. 4 · Issue 2 · pp. 83–85

  https://doi.org/10.4103/0976-500X.110868
  Full text ↗PDF

• Case ReviewOpen Access

  Nexavar®-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012

  Felisa Cilurzo, Orietta Staltari, Marinella Patanè, Michele Ammendola, Caterina Garaffo, Eugenio Donato Paola

  Vol. 4 · Issue 1 · pp. S86–S86

  https://doi.org/10.4103/0976-500X.120971
  Full text ↗PDF

• EditorialOpen Access

  Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance

  Emilio Russo, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. 1–3

  https://doi.org/10.4103/0976-500X.120938
  Full text ↗PDF